MANUEL
MORO SERRANO
Investigador en el periodo 2009-2016
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (9)
2012
-
Five-year antibody persistence and safety following a booster dose of combined haemophilus influenzae type b-neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine
Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1074-1077
-
Perfil serológico en gestantes extranjeras frente a VIH, VHB, VHC, virus de la rubéola, Toxoplasma gondii, Treponema pallidum, y Trypanosoma cruzi
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 2, pp. 64-69
2008
-
Immunogenicity and reactogenicity of a booster dose of a novel combined haemophilus influenzae type b-neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age
Pediatric Infectious Disease Journal, Vol. 27, Núm. 7, pp. 579-588
-
Probable early-onset group B streptococcal neonatal sepsis: A serious clinical condition related to intrauterine infection
Archives of Disease in Childhood: Fetal and Neonatal Edition, Vol. 93, Núm. 2
2007
-
Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission
BMC Pediatrics, Vol. 7
-
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months
Pediatric Infectious Disease Journal, Vol. 26, Núm. 1, pp. 1-7
2006
-
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine
Pediatric Infectious Disease Journal, Vol. 25, Núm. 8, pp. 713-720
-
Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin
BMC Pediatrics, Vol. 6
2005
-
Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention
Acta Paediatrica, International Journal of Paediatrics, Vol. 94, Núm. 4, pp. 451-457